{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:22:25Z","timestamp":1775841745181,"version":"3.50.1"},"reference-count":11,"publisher":"Massachusetts Medical Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,2,27]]},"DOI":"10.1056\/nejmc2416778","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T22:00:21Z","timestamp":1740607221000},"page":"930-932","source":"Crossref","is-referenced-by-count":2,"title":["Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B"],"prefix":"10.1056","volume":"392","member":"150","reference":[{"key":"e_1_2_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405485"},{"key":"e_1_2_3_3_3_2","unstructured":"Xie C Xie D-Y Fu L et al. Everest Project\u2019s 5-year update: efficacy of PegIFN-a therapy in HBeAg- CHB patients in China. In: Proceedings and Abstracts of the 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver March 27\u201331 2024. Kyoto Japan: Asian Pacific Association for the Study of the Liver 2024."},{"key":"e_1_2_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000431"},{"key":"e_1_3_3_3_2_2","unstructured":"Xie C Xie D Xu Q et al. The Everest Project\u2019s 5-year update: efficacy of PegIFN\u03b1 therapy in NA-suppressed HBeAg negative CHB. In: Proceedings and Abstracts of the 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver March 27\u201331 2024. Kyoto Japan: Asian Pacific Association for the Study of the Liver 2024."},{"key":"e_1_3_3_3_3_2","first-page":"1003","article-title":"Immunomodulatory and antiviral therapy improved functional cure rate in CHB patients with high HBsAg level experienced NA.","volume":"11","author":"Jia H","year":"2023","unstructured":"Jia H, Yu G, Yu J, et al. Immunomodulatory and antiviral therapy improved functional cure rate in CHB patients with high HBsAg level experienced NA. J Clin Transl Hepatol 2023;11:1003-1010.37577218","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_3_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779347"},{"key":"e_1_3_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.003"},{"key":"e_1_4_3_3_2_2","unstructured":"Xie C Xie D-Y Fu L et al. Everest Project\u2019s 5-year update: efficacy of PegIFN-a therapy in HBeAg- CHB patients in China. In: Proceedings and Abstracts of the 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver March 27\u201331 2024. Kyoto Japan: Asian Pacific Association for the Study of the Liver 2024."},{"key":"e_1_4_3_3_3_2","first-page":"1003","article-title":"Immunomodulatory and antiviral therapy improved functional cure rate in CHB patients with high HBsAg level experienced NA.","volume":"11","author":"Jia H","year":"2023","unstructured":"Jia H, Yu G, Yu J, et al. Immunomodulatory and antiviral therapy improved functional cure rate in CHB patients with high HBsAg level experienced NA. J Clin Transl Hepatol 2023;11:1003-1010.37577218","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_4_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779347"},{"key":"e_1_4_3_3_5_2","unstructured":"Hou J Xie Q Zhang W et al. Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapy in chronic hepatitis B: 48 week follow-up results from Piranga a phase 2 randomized controlled adaptive open-label platform study. In: Proceedings and abstracts of the 2024 AASLD Liver Meeting November 15\u201319 2024. San Diego CA: American Association for the Study of Liver Diseases 2024."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc2416778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:32:19Z","timestamp":1749681139000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc2416778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,2,27]]}},"alternative-id":["10.1056\/NEJMc2416778"],"URL":"https:\/\/doi.org\/10.1056\/nejmc2416778","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}